Company intelligence / Profile preview
FRILAB
Geneva, Geneva, Switzerlandfrilab.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
FRILAB Laboratories commercializes a broad range of pharmaceutical products for various health indications, focusing on emerging markets, and supplies both in-house and in-licensed molecules that meet European quality standards. There is no public disclosure of recent clinical trial results; the company appears to specialize in supply, registration, and distribution, rather than novel drug discovery and clinical stage R&D[1][2][3][7].
- Therapeutic areas
- Women's HealthMetabolic DisordersOther
- Modalities
- Small moleculeBiologicProteinRecombinant protein
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
Local certified exporters and manufacturers in Africa, Middle East, Eurasia, Maghreb, South America, and Southeast Asia[1][2].
Beyond the preview
Go deeper on FRILAB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FRILAB.